To assess whether LC diets are associated with long-term improvement in glycemic control and weight loss in people with T2DM, and their cardiovascular and renal safety.
Meta-analysis of randomized controlled trials lasting more than 3 months, retrieved through extensive search on PubMed, Embase, ClinicalTrial.gov, Cochrane databases up to March 1st, comparing LC diets and balanced carbohydrate diets in people with T2DM.
We retrieved 37 trials, including 3301 patients. Average carbohydrate intake in LC diets was 36% of total energy. LC diets were associated with significant reduction of HbA1c at 3 months (MD − 0.17%, 95% CI − 0.27, − 0.07), no difference at 6 and 12 months, and significant increase at 24 months (MD 0.23%, 95% CI MD 0.02, 0.44). VLC diets were associated with significant HbA1c reduction at 3 and 6 months (MD − 0.43% − 0.60, − 0.26%, and MD − 0.40% 95% CI − 0.59, − 0.22, respectively), but not at 12 and 24 months. LC diets were associated with significant BMI reduction at 6 months (− 1.35 kg/m2 95% CI, − 2.18, − 0.52), but not at other time points. Only a minority of trials reported data on renal function, so renal safety could not be assessed. No significant differences in body weight, lipid profile, or blood pressure were found in the long term.
LC diets may produce small short-term improvements in HbA1c and weight, which are not maintained in the long term. Data on their renal safety are insufficient.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Care D, Suppl SS (2019) 5. Lifestyle management: standards of medical care in diabetesd2019. Diabetes Care 42(January):S46–S60
Colosia AD, Palencia R, Khan S (2013) “Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes Targets Ther 6:327–338
Hanefeld M, Koehler C, Gallo S, Benke I, Ott P (2007) Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: The Diabetes in Germany (DIG) study. Cardiovasc Diabetol 6:1–7
Mann J (1984) From Lines to Legumes: changing concepts of diabetic diets. Diabet Med 1(June):191–198
Van Eck WF (1959) The effect of a low fat diet on the serum lipids in diabetes and its significance in diabetic retinopathy. Am J Med 27(2):196–211
Trichopoulou A, Costacou T, Bamia C, Trichopoulos D (2003) Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 348(26):2599–2608
Bueno NB, De Melo ISV, De Oliveira SL, Da Rocha Ataide T (2013) Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of Randomised controlled trials. Br J Nutr 110(7):1178–1187
Pagoto SL, Appelhans BM (2013) A call for an end to the diet debates. JAMA J Am Med Assoc 310(7):687–688
Wrone EM, Carnethon MR, Palaniappan L, Fortmann SP (2003) Association of dietary protein intake and microalbuminuria in healthy adults: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41(3):580–587
Malhotra R et al (2018) Protein intake and long-term change in glomerular filtration rate in the Jackson Heart Study. J Ren Nutr 28(4):245–250
Medical Diabetologist Association-Italian Diabetology Society (2018) Italian Standards for diabetes mellitus care 2018.
Korsmo-Haugen HK, Brurberg KG, Mann J, Aas AM (2019) “Carbohydrate quantity in the dietary management of type 2 diabetes: a systematic review and meta-analysis. Diabetes Obes Metab 21(1):15–27
Ajala O, English P, Pinkney J (2013) Systematic review and meta-analysis of different dietary approaches. Send Am J Clin Nutr 97(3):5005–5516
Moher D et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:7
Italian Society of human nutrition (2014) LARN: Nutrients and energy intake standard levels for the Italian population: 4th revision
(2015) Scientific Opinion on the essential composition of total diet replacements for weight control. EFSA J. 13(1):3957.
Sheard NF et al (2004) Dietary carbohydrate (amount and type) in the prevention and management of diabetes. Diabetes Care 27(9):2266–2271
Higgins JPT et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343(7829):1–9
Liu K et al (2018) Effect of combined use of a low-carbohydrate, high-protein diet with omega-3 polyunsaturated fatty acid supplementation on glycemic control in newly diagnosed type 2 diabetes: a randomized, double-blind, parallel-controlled trial. Am J Clin Nutr 108(2):256–265
Sato J et al (2017) A randomized controlled trial of 130 g/day low-carbohydrate diet in type 2 diabetes with poor glycemic control. Clin Nutr 36(4):992–1000
Krebs JD et al (2012) The diabetes excess weight loss (DEWL) trial: a randomised controlled trial of high-protein versus high-carbohydrate diets over 2 years in type 2 diabetes. Diabetologia 55(4):905–914
Luger M, Holstein B, Schindler K, Kruschitz R, Ludvik B (2013) Feasibility and efficacy of an isocaloric high-protein vs standard diet on insulin requirement, body weight and metabolic parameters in patients with type 2 diabetes on insulin therapy. Exp Clin Endocrinol Diabetes 121(5):286–294
Tay J et al (2014) A very low-carbohydrate, low-saturated fat diet for type 2 diabetes management: a randomized trial. Diabetes Care 37(11):2909–2918
Larsen RN, Mann NJ, Maclean E, Shaw JE (2011) The effect of high-protein, low-carbohydrate diets in the treatment of type 2 diabetes: a 12 month randomised controlled trial. Diabetologia 54(4):731–740
Pedersen E, Jesudason DR, Clifton PM (2014) High protein weight loss diets in obese subjects with type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 24(5):554–562
Wycherley TP, Noakes M, Clifton PM, Cleanthous X, Keogh JB, Brinkworth GD (2010) A high-protein diet with resistance exercise training improves weight loss and body composition in overweight and obese patients with type 2 diabetes. Diabetes Care 33(5):969–976
Yamada Y et al (2014) A non-calorie-restricted low-carbohydrate diet is effective as an alternative therapy for patients with type 2 diabetes. Intern Med 53(1):13–19
Levey J, Coresh AS (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating filtration glomerular rate. Ann Intern Med
Sainsbury E, Kizirian NV, Partridge SR, Gill T, Colagiuri S, Gibson AA (2018) Effect of dietary carbohydrate restriction on glycemic control in adults with diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract 139:239–252
Schwingshackl L, Chaimani A, Hoffmann G, Schwedhelm C, Boeing H (2018) A network meta-analysis on the comparative efficacy of different dietary approaches on glycaemic control in patients with type 2 diabetes mellitus. Eur J Epidemiol 33(2):157–170
Sedgwick P (2015) Intention to treat analysis versus per protocol analysis of trial data. BMJ 350(February):1–2
Snorgaard O, Poulsen GM, Andersen HK, Astrup A (2017) Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes. BMJ Open Diabetes Res Care 5:1
Lentine K, Wrone EM (2004) New insights into protein intake and progression of renal disease. Curr Opin Nephrol Hypertens 13(3):333–336
Hammad S, Pu S, Jones PJ (2016) Current evidence supporting the link between dietary fatty acids and cardiovascular disease. Lipids 51(5):507–517
Fidanza F, Alberti A, Lanti M, Menotti A (2004) Mediterranean Adequacy Index: Correlation with 25-year mortality from coronary heart disease in the Seven Countries Study. Nutr Metab Cardiovasc Dis 14(5):254–258
This research was performed as a part of the institutional activity of the unit, with no specific funding. The manuscript was drafted and revised by the authors in accordance with ICJME standards for authorship. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Conflict of interest
GAS and ID have received speaking fees from Astra Zeneca, Novonordisk; LB, VG, and FG have no conflict of interest; MM has received speaking fees from Astra Zeneca, Bristol Myers Squibb, Boehringer-Ingelheim, Eli-Lilly, Merck, Novo Nordisk, Sanofi, and Novartis and research grants from Bristol Myers Squibb; EM has received consultancy fees from Merck and Novartis speaking fees from Astra Zeneca, Bristol Myers Squibb, Boehringer-Ingelheim, Eli-Lilly, Merck, Novo Nordisk, Sanofi, and Novartis and research grants from Merck, Novartis, and Takeda.
Ethical standard statement or human and animal rights disclosure
This article does not contain any studies with human participants or animals performed by any of the authors.
The present study is a meta-analysis, therefore Informed consent is not required.
Managed by Antonio Secchi.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Silverii, G.A., Botarelli, L., Dicembrini, I. et al. Low-carbohydrate diets and type 2 diabetes treatment: a meta-analysis of randomized controlled trials. Acta Diabetol 57, 1375–1382 (2020). https://doi.org/10.1007/s00592-020-01568-8
- Type 2 diabetes mellitus
- Low-carbohydrate diets